Abstract
Purpose
Induction of labor among pregnant women with high levels of total bile acid (TBA) is common among clinicians. We examined, if women with intrahepatic cholestasis of pregnancy (ICP) and TBA ≥ 40 μmol/l have a higher risk of maternal–fetal complications, when labor is induced at 37 weeks of gestation, compared with induction of labor at term in women with low-risk ICP.
Methods
Retrospective cohort study of 16,185 women delivering at Roskilde University Hospital in the period 2006–2011. Women with high-risk ICP (TBA ≥ 40 μmol/l) had labor induced at 37 weeks of gestation; women with low-risk ICP (TBA < 40 μmol/l) at term.
Outcomes
Mode of delivery, duration of induction procedures, highest level of TBA and alanine aminotransferase (ALT) and for the neonates: Apgar scores at 5 min, umbilical cord pHs and SBEs, NICU admissions and birthweights.
Results
The incidences of ICP was 1.2 % (95 % CI 1.05–1.39 %) altogether and for high-risk ICP 0.4 % (95 % CI 0.27–0.46 %). No difference was found in mode of delivery, length of induction of labor nor in neonatal outcomes, except for an expected difference in birthweight. In high-risk ICP, ALT was not raised in 10.3 % (95 % CI 2.5–18.2 %).
Conclusion
Early induction of labor at 37 weeks of gestation seems justified in high-risk ICP, as, except for abbreviating gestational age by 9 days with 296 g smaller babies, induction of labor was not followed by detectable maternal–fetal disadvantages and is favored by an expected major reduction in ICP stillbirth risk.
Similar content being viewed by others
Notes
Until November 25th 2009 the Reactionlab A/S—BIO-STAT Bile Acid kit (Cat.no. 495000) was used. The kit was calibrated by performing measurements in parallel with the laboratorium in Gothenburg that performed the analyses in the large Swedish prospective study by A. Glantz (1) and was accordingly corrected by a factor 40/30; later a Sentinel Bile Acids TBA (REF 6K9001) were used and calibrated against its standard.
References
Glantz A, Marschall HU, Mattsson LA (2004) Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 40(2):467–474
Fisk NM, Storey GN (1988) Fetal outcome in obstetric cholestasis. Br J Obstet Gynaecol 95(11):1137–1143
Geenes V, Williamson C (2009) Intrahepatic cholestasis of pregnancy. World J Gastroenterol 15(17):2049–2066
Rioseco AJ, Ivankovic MB, Manzur A, Hamed F, Kato SR, Parer JT et al (1994) Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol 170(3):890–895
Reid R, Ivey KJ, Rencoret RH, Storey B (1976) Fetal complications of obstetric cholestasis. Br Med J 1(6014):870–872
Geenes V, Chappell LC, Seed PT, Steer PJ, Knight M, Williamson C (2014) Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study. Hepatology 59(4):1482–1491
Pata O, Vardareli E, Ozcan A, Serteser M, Unsal I, Saruc M et al (2011) Intrahepatic cholestasis of pregnancy: correlation of preterm delivery with bile acids. Turk J Gastroenterol 22(6):602–605
Oztekin D, Aydal I, Oztekin O, Okcu S, Borekci R, Tinar S (2009) Predicting fetal asphyxia in intrahepatic cholestasis of pregnancy. Arch Gynecol Obstet 280(6):975–979
Wikstrom Shemer E, Marschall HU, Ludvigsson JF, Stephansson O (2013) Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study. BJOG 120(6):717–723
Joutsiniemi T, Timonen S, Leino R, Palo P, Ekblad U (2014) Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: a randomized controlled trial. Arch Gynecol Obstet 289(3):541–547
Chappell LC, Gurung V, Seed PT, Chambers J, Williamson C, Thornton JG (2012) Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial. BMJ 344:e3799
Germain AM, Kato S, Carvajal JA, Valenzuela GJ, Valdes GL, Glasinovic JC (2003) Bile acids increase response and expression of human myometrial oxytocin receptor. Am J Obstet Gynecol 189(2):577–582
Kondrackiene J, Beuers U, Zalinkevicius R, Tauschel HD, Gintautas V, Kupcinskas L (2007) Predictors of premature delivery in patients with intrahepatic cholestasis of pregnancy. World J Gastroenterol 13(46):6226–6230
Brouwers L, Koster MP, Page-Christiaens GC, Kemperman H, Boon J, Evers IM et al (2015) Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels. Am J Obstet Gynecol 212(1):100 e1–100 e7
Geenes VL, Lim YH, Bowman N, Tailor H, Dixon PH, Chambers J et al (2011) A placental phenotype for intrahepatic cholestasis of pregnancy. Placenta 32(12):1026–1032
Silver RM, Parker CB, Goldenberg R, Reddy UM, Dudley DJ, Saade GR et al (2014) Bile acids in a multicenter, population-based case-control study of stillbirth. Am J Obstet Gynecol 210:460.e1-9
Suri V, Jain R, Aggarwal N, Chawla YK, Kohli KK (2012) Usefulness of fetal monitoring in intrahepatic cholestasis of pregnancy: a prospective study. Arch Gynecol Obstet 286(6):1419–1424
Williamson C, Hems LM, Goulis DG, Walker I, Chambers J, Donaldson O et al (2004) Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group. BJOG 111(7):676–681
Puljic A, Kim E, Page J, Esakoff T, Shaffer B, LaCoursiere DY et al (2015) The risk of infant and fetal death by each additional week of expectant management in intrahepatic cholestasis of pregnancy by gestational age. Am J Obstet Gynecol 212:667.e1-5
Wikstrom Shemer EA, Thorsell M, Marschall HU, Kaijser M (2013) Risks of emergency cesarean section and fetal asphyxia after induction of labor in intrahepatic cholestasis of pregnancy: a hospital-based retrospective cohort study. Sex Reprod Health 4(1):17–22
Abedin P, Weaver JB, Egginton E (1999) Intrahepatic cholestasis of pregnancy: prevalence and ethnic distribution. Ethn Health 4(1–2):35–37
Lee RH, Goodwin TM, Greenspoon J, Incerpi M (2006) The prevalence of intrahepatic cholestasis of pregnancy in a primarily Latina Los Angeles population. J Perinatol 26(9):527–532
Laatikainen T, Tulenheimo A (1984) Maternal serum bile acid levels and fetal distress in cholestasis of pregnancy. Int J Gynaecol Obstet 22(2):91–94
Alsulyman OM, Ouzounian JG, Ames-Castro M, Goodwin TM (1996) Intrahepatic cholestasis of pregnancy: perinatal outcome associated with expectant management. Am J Obstet Gynecol 175(4 Pt 1):957–960
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical standards
The Danish Data Protection Agency approved the study (file number: SN-21-2012). No ethic approval was neccesary for this study according to The National Committee on Health Research Ethics.
Rights and permissions
About this article
Cite this article
Friberg, A.K., Zingmark, V. & Lyndrup, J. Early induction of labor in high-risk intrahepatic cholestasis of pregnancy: what are the costs?. Arch Gynecol Obstet 294, 709–714 (2016). https://doi.org/10.1007/s00404-016-4019-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-016-4019-8